General Information of the Compound
Compound ID
CP0134398
Compound Name
(LY-171883)1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone
    Show/Hide
Synonyms
LY-171883
Tomelukast
    Show/Hide
Structure
Formula
C16H22N4O3
Molecular Weight
318.377
Canonical SMILES
CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O
    Show/Hide
InChI
InChI=1S/C16H22N4O3/c1-3-6-13-14(9-8-12(11(2)21)16(13)22)23-10-5-4-7-15-17-19-20-18-15/h8-9,22H,3-7,10H2,1-2H3,(H,17,18,19,20)
    Show/Hide
InChIKey
MWYHLEQJTQJHSS-UHFFFAOYSA-N
Physicochemical Property
logP
2.4621
Rotatable Bonds
9
Heavy Atom Count
23
Polar Areas
100.99
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3969
SID: 46526737
ChEMBL ID
CHEMBL162358
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 316.2 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Tomelukast )
Drug Name Tomelukast
Company Eli Lilly & Co
Indication
Asthma
Terminated
Target(s)
Leukotriene CysLT1 receptor (CYSLTR1)
Modulator